John C. Downing
Impact in
-
- Carcinogens and Genotoxicity Assessment
- Pharmacology top 10%
- Pharmacogenetics and Drug Metabolism
Papers in
-
- Epigenetics and DNA Methylation 1
-
- Pituitary Gland Disorders and Treatments 2
- Co-authors
- R. Michael McClain (7 shared papers)Arthur S. Tischler (3 shared papers)Jennifer L. Counts (1 shared paper)Margaret L. Harbison (1 shared paper)Juan I. Sarmiento‐Sánchez (1 shared paper)Jay I. Goodman (1 shared paper)Henry Childers (1 shared paper)John Whysner (1 shared paper)
- Journals
- Toxicology and Applied Pharmacology (4 papers)Toxicological Sciences (1 paper)Carcinogenesis (1 paper)Toxicologic Pathology (1 paper)PubMed (1 paper)
- Partner nations
- United StatesSwitzerlandNetherlands
In The Last Decade
John C. Downing
8 papers receiving 364 citations
Peers
Comparison fields: 5 of 63
- Cancer Research 108
- Pharmacology 66
- Endocrinology, Diabetes and Metabolism 110
- Health, Toxicology and Mutagenesis 98
- Chemical Health and Safety 2
Countries citing papers authored by John C. Downing
This map shows the geographic impact of John C. Downing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John C. Downing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John C. Downing more than expected).
Fields of papers citing papers by John C. Downing
This network shows the impact of papers produced by John C. Downing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John C. Downing. The network helps show where John C. Downing may publish in the future.
Co-authors
The 16 scholars most cited alongside John C. Downing, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1989 | 172 | |
| 2 | 1996 | 82 | |
| 3 | 1998 | 42 | |
| 4 | 1996 | 30 | |
| 5 | Neurogenic signals regulate chromaffin cell proliferation and mediate the mitogenic effect of reserpine in the adult rat adrenal medulla. | 1991 | 28 |
| 6 | 2009 | 18 | |
| 7 | 1995 | 16 | |
| 8 | 1989 | 4 |
About John C. Downing
John C. Downing is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism, Infectious Diseases, Oncology and Cancer Research, having authored 8 papers that have together received 392 indexed citations. Recurring topics across this work include Pituitary Gland Disorders and Treatments (2 papers), Pharmacogenetics and Drug Metabolism (1 paper), Cardiac electrophysiology and arrhythmias (1 paper), Epigenetics and DNA Methylation (1 paper), Amino Acid Enzymes and Metabolism (1 paper), Acute Myocardial Infarction Research (1 paper), Neuroscience and Neuropharmacology Research (1 paper) and Drug Transport and Resistance Mechanisms (1 paper). The work is most often cited by research in Cancer Research (108 citations), Pharmacology (66 citations), Endocrinology, Diabetes and Metabolism (110 citations), Health, Toxicology and Mutagenesis (98 citations) and Chemical Health and Safety (2 citations). John C. Downing has collaborated with scholars based in United States, Switzerland and Netherlands. Frequent co-authors include R. Michael McClain, Arthur S. Tischler, Jennifer L. Counts, Margaret L. Harbison, Juan I. Sarmiento‐Sánchez, Jay I. Goodman, Henry Childers, John Whysner, Gary M. Williams and Lynne Verna. Their work appears in journals such as Toxicology and Applied Pharmacology, Toxicological Sciences, Carcinogenesis, Toxicologic Pathology and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.